Cargando…
Insights into the mechanism of C5aR inhibition by PMX53 via implicit solvent molecular dynamics simulations and docking
BACKGROUND: The complement protein C5a acts by primarily binding and activating the G-protein coupled C5a receptor C5aR (CD88), and is implicated in many inflammatory diseases. The cyclic hexapeptide PMX53 (sequence Ace-Phe-[Orn-Pro-dCha-Trp-Arg]) is a full C5aR antagonist of nanomolar potency, and...
Autores principales: | Tamamis, Phanourios, Kieslich, Chris A, Nikiforovich, Gregory V, Woodruff, Trent M, Morikis, Dimitrios, Archontis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141665/ https://www.ncbi.nlm.nih.gov/pubmed/25170421 http://dx.doi.org/10.1186/2046-1682-7-5 |
Ejemplares similares
-
Insights into the Structure, Correlated Motions, and Electrostatic Properties of Two HIV-1 gp120 V3 Loops
por: López de Victoria, Aliana, et al.
Publicado: (2012) -
Preclinical Pharmacokinetics of Complement C5a Receptor
Antagonists PMX53 and PMX205 in Mice
por: Kumar, Vinod, et al.
Publicado: (2020) -
Development and validation of a LC-MS/MS assay for pharmacokinetic studies of complement C5a receptor antagonists PMX53 and PMX205 in mice
por: Kumar, Vinod, et al.
Publicado: (2018) -
Virtual Screening of Chemical Compounds for Discovery of Complement C3 Ligands
por: Mohan, Rohith R., et al.
Publicado: (2018) -
Highly Accurate Structure-Based Prediction of HIV-1 Coreceptor Usage Suggests Intermolecular Interactions Driving Tropism
por: Kieslich, Chris A., et al.
Publicado: (2016)